| Rebecca Lauren Harshman, OTR/L | |
|
10050 Legacy Dr Ste 200, Frisco, TX 75033-6752 | |
| (214) 494-4677 | |
| (469) 579-4090 |
| Full Name | Rebecca Lauren Harshman |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 10050 Legacy Dr Ste 200, Frisco, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073104105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 120972 (Texas) | Primary |
| Provider Name | Summit Speech Therapy, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538562897 PECOS PAC ID: 4587996459 Enrollment ID: O20191025000417 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
Women with dense breasts and no lobular involution were at a higher risk for developing breast cancer than those with non-dense breasts and complete involution, according to a study published online in The Journal of the National Cancer Institute.
As part of a unique survey of nearly 2,000 women of childbearing age who receive health care at the nation's community health centers, 90 percent reported that they were not actively seeking to become pregnant in the next 12 months. Yet more than 3 out of 10 were not using contraceptives at the time of the survey.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, today announced top-line data from a randomized Phase II clinical study of its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Lauren Harshman, OTR/L 6405 Northridge Pkwy, Parker, TX 75002-5557 Ph: (469) 734-2666 | Rebecca Lauren Harshman, OTR/L 10050 Legacy Dr Ste 200, Frisco, TX 75033-6752 Ph: (214) 494-4677 |
News Archive
Genetics researchers have identified a key gene that, when mutated, causes the rare multisystem disorder Cornelia deLange syndrome (CdLS). By revealing how mutations in the HDAC8 gene disrupt the biology of proteins that control both gene expression and cell division, the research sheds light on this disease, which causes intellectual disability, limb deformations and other disabilities resulting from impairments in early development.
Women with dense breasts and no lobular involution were at a higher risk for developing breast cancer than those with non-dense breasts and complete involution, according to a study published online in The Journal of the National Cancer Institute.
As part of a unique survey of nearly 2,000 women of childbearing age who receive health care at the nation's community health centers, 90 percent reported that they were not actively seeking to become pregnant in the next 12 months. Yet more than 3 out of 10 were not using contraceptives at the time of the survey.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, today announced top-line data from a randomized Phase II clinical study of its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 or high-risk myelodysplastic syndrome (MDS).
› Verified 1 days ago
Rahael Butris, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2949 Parkwood Blvd, Apt 244, Frisco, TX 75034 Phone: 214-435-2480 Fax: 214-975-2186 | |
Tara Byrum, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5192 | |
Cub Cave Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3900 Siena Dr, Frisco, TX 75033 Phone: 832-331-0080 | |
Meredith Simone, MOT OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5176 Fax: 469-888-5175 | |
Kelly Ann Espinoza, MBA, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11092 Snyder Dr, Frisco, TX 75035 Phone: 469-328-6024 | |
Richard Bryant Jones, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9200 World Cup Way, Suite 201, Frisco, TX 75033 Phone: 972-712-2669 | |
Jodi Dietz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 255 W Lebanon Ste 316, Frisco, TX 75036 Phone: 817-479-7019 |